Private Equity

Updated:

Templeton World Charity Foundation

Templeton World Charity Foundation is a private equity based in Nassau, founded 1996; the Altss profile covers its classification, headquarters, registration,...

Templeton World Charity Foundation logo

Templeton World Charity Foundation

Templeton World Charity Foundation funds innovative projects that push the boundaries of scientific knowledge and help people flourish.

General information

Firm type

Private Equity

Year founded

1996

Location

Region

North America

Country

Bahamas

City

Nassau

Corporate office

Nassau, Bahamas

Principals

John M. Templeton Jr.

Founding Chairman (deceased)

Dr. Andrew Serazin

President

Sector focus

Scientific ResearchMoral & Spiritual DevelopmentNeuroscienceMental HealthDevelopmental Biology

Frequently asked questions

How is the Templeton World Charity Foundation distinct from the John Templeton Foundation?

The Templeton World Charity Foundation, based in the Bahamas, operates as an international grantmaking charity with a focus on global scientific research and open-science initiatives. The John Templeton Foundation, headquartered in Pennsylvania, is a separate US-based foundation that funds research and public programs on similar themes of science and the big questions. Both were established by Sir John Templeton but operate with independent governance, investment portfolios, and grantmaking strategies.

Does the foundation make direct venture investments or equity commitments?

No. The Templeton World Charity Foundation is a traditional philanthropic grantmaker, not an investment firm. It deploys capital through structured grants, prize competitions, and funding partnerships with research institutions rather than through direct equity investments, venture capital-style deals, or fund commitments. The endowment's investment portfolio is managed separately to generate the income that funds these grants.

What does the foundation’s investment portfolio look like?

The foundation maintains a globally diversified endowment portfolio consistent with Sir John Templeton's investment philosophy, though specific asset allocations, holdings, and manager relationships are not publicly disclosed. The portfolio was built from the founder's proceeds from the Templeton Growth Fund and subsequent Franklin Resources transaction, with the investment objective of generating sustainable annual returns to support grantmaking operations.

Who leads the foundation's grantmaking and operations?

Dr. Andrew Serazin serves as the foundation's President, overseeing its strategic direction, grantmaking priorities, and global operations. He has championed the foundation's focus on open-science platforms, interdisciplinary research networks, and funding for early-career scientists. The board includes independent directors and members connected to the Templeton family legacy, though the foundation operates independently of the family's other philanthropic entities.

How can researchers access the foundation's funding?

The foundation runs periodic open calls, including the Templeton Ideas Challenge, which creates structured pathways for scientists and research institutions to apply for funding in thematic areas such as neuroscience, mental health, and human flourishing. Grant applications are reviewed through a competitive selection process, with the foundation prioritizing projects that bridge disciplinary boundaries and address existential scientific questions.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Nassau Private Equity profiles